Conference Coverage
Latest News
Sep 15, 2026 | Opinion
Jonathan Harper, MD, on the importance of fluid intake for reducing stone recurrence
Topical sildenafil cream associated with lower systemic exposure vs oral sildenafil
Sep 15, 2026
Cameron Jones, MD, discusses patient selection for Aquablation
Sep 15, 2026
PSMA-targeted CD28 bispecific enters phase 1 trial in mCRPC
Sep 14, 2026
Andrew Peterson, MD, discusses advances in artificial urinary sphincter technology
Sep 14, 2026
Advertisement
Shorts
0:51
How to spot patients chasing a product, not a diagnosis
16 hours ago
by
Jean Cunningham, PharmD, BCPS
0:24
How NeoBLAST defines and confirms complete response
2 days ago
by
Marie-Pier St-Laurent, MD, FRCSC
1:09
Considering the practical benefits of intraoperative chemotherapy at nephroureterectomy
5 days ago
by
Adam B. Weiner, MD(+1 more)
0:22
What the evidence says on penile cancer margin management
6 days ago
by
Luis G. Medina, MD
0:21
4 steps to implementing a rapid access model for elevated PSA
7 days ago
by
Zach Feuer, MD
0:30
The ambition behind the first MIBC surveillance RCT
8 days ago
by
Marie-Pier St-Laurent, MD, FRCSC
0:51
Why GLP-1 and TRT combinations require careful sequencing
9 days ago
by
Jean Cunningham, PharmD, BCPS
0:49
How urologists can support the State of Men’s Health Act
12 days ago
by
Mark T. Edney, MD
1:13
Streamlining elevated PSA evaluation through telehealth
13 days ago
by
Zach Feuer, MD
0:26
Selecting patients for bladder-sparing surveillance
14 days ago
by
Marie-Pier St-Laurent, MD, FRCSC
From GSM guidance to HRT reform: A landmark year for women’s health
2025 featured multiple advancements in women's health aimed at enhancing treatment options and awareness.
Inguinal lymph node dissection in penile cancer
"Deep ILND is indicated for clinically positive lymph nodes and/or positive lymph nodes on frozen pathological analysis of the superficial nodal packet," write Bahrom J. Ostad, MD, and Stephen H. Culp, MD, PhD, FACS.
Inside HoLEP: Irina Jaeger, MD, discusses patient selection and technique
Jaeger emphasizes that the ideal HoLEP candidate is any patient with bothersome lower urinary tract symptoms due to BPH, including those with urinary retention or intolerance to medication.
Podcasts
Videos
Urology Times Digital Edition
"Deep ILND is indicated for clinically positive lymph nodes and/or positive lymph nodes on frozen pathological analysis of the superficial nodal packet," write Bahrom J. Ostad, MD, and Stephen H. Culp, MD, PhD, FACS.
"The overall 0% impact to urology does not help urology practices deal with increasing costs incurred for staff, rent, supplies, and other overhead," write Jonathan Rubenstein, MD, and Mark Painter.
"If 2025 showed us anything, it is the power of combining scientific progress with public engagement," writes Michael S. Cookson, MD, MMHC, FACS.
"Once money is in a Roth IRA, the withdrawal rules depend on whether the funds are contributions, conversions, or earnings," writes Julie Khazan, CFP.
The approval is supported by results from the phase 3 KEYNOTE-905/EV-303 trial.
The ExactVu micro-ultrasound platform demonstrated noninferior detection of clinically significant prostate cancer vs MRI.
"The OBBA includes broad and sweeping changes that will have a profound impact," writes Allan Shen, CFP.
The ENDURE 1 study plans to enroll up to 60 patients with benign ureteric strictures.
The phase 3 PSMAddition trial assessed the combination of 177Lu-PSMA-617 plus ADT/ARPI in an earlier stage of metastatic prostate cancer.
Jaeger emphasized that the ideal HoLEP candidate is any patient with bothersome lower urinary tract symptoms due to BPH, including those with urinary retention or intolerance to medication
Continuing Medical Education
Advertisement
All News
Advertisement
Eugene Cone, MD, discusses the impact of ongoing BCG supply challenges and the potential role of alternative and recombinant strains for NMIBC care.
Independent urology faces stagnant Medicare pay, rising costs, prior auth burden, and consolidation pressure, Celeste Kirschner, CAE, MHSA, says.
In this episode, Karen Bigman, MBA, joins to discuss sexual health, intimacy, and relationship challenges facing adults as they navigate midlife and beyond.
Lorelei A. Mucci, ScD, MPH, discusses the evolving evidence surrounding diet, physical activity, and other lifestyle factors in prostate cancer care.
Urologists compare ADT plus ARPI doublets and docetaxel triplets in mCSPC, weighing efficacy, safety, cognition, and cost against patient goals.
All patients have been treated in the phase 3 ENLIGHTED trial, evaluating padeliporfin VTP for low-grade upper tract urothelial carcinoma.
Martin Schoen, MD, PhD, explains how real-world evidence can help compare ARPIs and why study design and patient selection are critical to interpretation.
John P. Sfakianos, MD, discusses the challenges of managing recurrent LG-IR-NMIBC and the role of chemoablation.
A randomized trial will test whether an app-guided, at-home PSA screening approach can improve prostate cancer screening among Black men.
Dabogratinib showed early activity and manageable safety in FGFR3-altered LG-IR-NMIBC, supporting advancement to a planned registrational study in the adjuvant setting.
Advertisement
Advocacy through groups like BCAN and the AUA shapes urologic oncology policy—driving funding, screening access, and equity in cancer care, the authors write.
The Zenflow Spring Implant and Delivery System has entered commercial use for BPH following its FDA approval in December 2025.
Scammers are stealing female urologists' headshots to run AI-driven catfishing and supplement scams; in this article, 2 urologists share their experiences with this concerning trend.
Rising patient interest in TRT, GLP-1s, and peptide stacking requires clinicians to anchor conversations in evidence tiers, use baseline DEXA scans to monitor body composition, and engage patient goals without endorsing unsupported claims.
Higher saturated and animal fat intake was linked to increased mortality among men with nonmetastatic prostate cancer, according to a cohort study published in JAMA Network Open.
Advertisement
Advertisement
Trending on Urology Times
1
Managing BPH Before Prostate Radiotherapy: Options Compared
2
Patient Selection and Partnership in Prostate Radiotherapy Spacing
3
Cameron Jones, MD, discusses patient selection for Aquablation
4
Andrew Peterson, MD, discusses advances in artificial urinary sphincter technology
5